Beğen
Yorum Yap
Paylaş
Kapağı yeniden konumlandırmak için sürükleyin
Daha fazla Mesajları yükle
Yaklaşık
Upajak (Upadacitinib) is a generic version of RINVOQ which is a selective Janus kinase (JAK) inhibitor used to treat inflammatory conditions such as rheumatoid arthritis, psoriatic arthritis, ulcerative colitis, atopic dermatitis, and ankylosing spondylitis. By specifically targeting JAK1, it helps regulate immune responses and reduce inflammation more effectively than traditional treatments.
Avatarını kırp